Unveiling the cutting edge breakthroughs in Cardio-Oncology. A glimpse into the forefront of medical advancements.
27th April 2024
.png)
Global mortality is heavily impacted by cardiovascular diseases and cancer. Scientific advancements have ushered in remarkable pharmacological and device innovations, significantly enhancing survival rates and potential cures for both conditions. However, oncological and hematological therapies, while altering disease progression, often bring about frequent cardiac toxicities. Chemotherapy, radiation, targeted, and immunotherapy have documented percentages of cardiotoxicities.
Simultaneously, cardiology has seen a leap in diagnostic methods, enabling early detection of toxicities and subclinical conditions. The emerging subspecialty of cardio-oncology aims to prevent today's cancer patients from becoming tomorrow's cardiac patients and aims to ensure existing cardiac conditions don’t hinder life-extending cancer therapy.
The first MEHA Cardio Oncology congress seeks to introduce this crucial concept to the UAE and GCC countries. It aims to heighten awareness and education among cardiologists, oncologists, and hematologists for early cardiovascular risk stratification, prevention and detection of cardiotoxicities, and prompt referral and management, ultimately elevating patient care standards.
We look forward to welcoming you in April 2024.
.jpg)
Congress Chairman,
Consultant - Cardiologist
Sheikh Shakbout Medical City
Abu Dhabi - UAE
10 Feb
20 Mar
10 Apr
19 Apr
We warmly welcome you to the scientific program of Middle East Cardio-Oncology Congress 2024, this meeting of minds promises to be a milestone in the realm of cardiac science.
The program has been meticulously designed to serve as a platform for sharing the latest breakthroughs and insights in cardiology. It encompasses a variety of engaging sessions that delve into the most advanced areas in cardiac sciences, promising a rich and enlightening experience.
We invite you to join us on this journey of exploration and discovery, as we collectively strive to enhance our understanding and treatment of cardiac conditions.
